Fig. 1

Impact of (A) Galangin, (B) SAHA, and (C) their combination on the viability of MDA-MB-231 cells. Morphological assessment of MDA-MB-231 cells: (D) Untreated control cells displaying normal morphology, (E) Galangin-induced morphological alterations, (F) SAHA-induced changes, and (G) Morphological effects resulting from the combined treatment with Galangin and SAHA